Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles
  • Search Articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article

Advertisement

ResearchIn-Press PreviewImmunologyInflammation Open Access | 10.1172/JCI206638

CD4+ T cell anergy in transplantation tolerance requires continuous Treg-dependent control of IL-2 availability

Alexandra Cassano,1 Domenic Abbondanza,1 Ying Wang,1 Shuang Wu,1 Christine M. McIntosh,1 Peter Wang,1 Jennifer B. Allocco,1 Montserrat Kwan,1 Ricardo Mora-Cartin,1 Ephraim Craddock,1 Michael S. Andrade,2 Anita S. Chong,2 and Maria L. Alegre1

1Section of Rheumatology, The University of Chicago, Chicago, United States of America

2Section of Transplantation, The University of Chicago, Chicago, United States of America

Find articles by Cassano, A. in: PubMed | Google Scholar |

1Section of Rheumatology, The University of Chicago, Chicago, United States of America

2Section of Transplantation, The University of Chicago, Chicago, United States of America

Find articles by Abbondanza, D. in: PubMed | Google Scholar |

1Section of Rheumatology, The University of Chicago, Chicago, United States of America

2Section of Transplantation, The University of Chicago, Chicago, United States of America

Find articles by Wang, Y. in: PubMed | Google Scholar

1Section of Rheumatology, The University of Chicago, Chicago, United States of America

2Section of Transplantation, The University of Chicago, Chicago, United States of America

Find articles by Wu, S. in: PubMed | Google Scholar

1Section of Rheumatology, The University of Chicago, Chicago, United States of America

2Section of Transplantation, The University of Chicago, Chicago, United States of America

Find articles by McIntosh, C. in: PubMed | Google Scholar

1Section of Rheumatology, The University of Chicago, Chicago, United States of America

2Section of Transplantation, The University of Chicago, Chicago, United States of America

Find articles by Wang, P. in: PubMed | Google Scholar |

1Section of Rheumatology, The University of Chicago, Chicago, United States of America

2Section of Transplantation, The University of Chicago, Chicago, United States of America

Find articles by Allocco, J. in: PubMed | Google Scholar

1Section of Rheumatology, The University of Chicago, Chicago, United States of America

2Section of Transplantation, The University of Chicago, Chicago, United States of America

Find articles by Kwan, M. in: PubMed | Google Scholar

1Section of Rheumatology, The University of Chicago, Chicago, United States of America

2Section of Transplantation, The University of Chicago, Chicago, United States of America

Find articles by Mora-Cartin, R. in: PubMed | Google Scholar

1Section of Rheumatology, The University of Chicago, Chicago, United States of America

2Section of Transplantation, The University of Chicago, Chicago, United States of America

Find articles by Craddock, E. in: PubMed | Google Scholar

1Section of Rheumatology, The University of Chicago, Chicago, United States of America

2Section of Transplantation, The University of Chicago, Chicago, United States of America

Find articles by Andrade, M. in: PubMed | Google Scholar |

1Section of Rheumatology, The University of Chicago, Chicago, United States of America

2Section of Transplantation, The University of Chicago, Chicago, United States of America

Find articles by Chong, A. in: PubMed | Google Scholar |

1Section of Rheumatology, The University of Chicago, Chicago, United States of America

2Section of Transplantation, The University of Chicago, Chicago, United States of America

Find articles by Alegre, M. in: PubMed | Google Scholar

Published November 19, 2026 - More info

J Clin Invest. https://doi.org/10.1172/JCI206638.
Copyright © 2026, Cassano et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published November 19, 2026 - Version history
View PDF
Abstract

Donor-specific transplantation tolerance promises to free recipients from complications associated with lifelong immunosuppression. Anergy, a CD4+ conventional T cell (Tconv)-intrinsic state of long-term hypofunction, is thought to arise when T cells encounter cognate antigen in the absence of costimulation. Anti-CD154 (αCD154), an antibody that blocks T cell costimulation and is currently in clinical trials, can induce donor-specific transplantation tolerance in mice in association with anergy of Tconvs recognizing persistently expressed alloantigens. Using murine models of fully mismatched cardiac allograft tolerance or repeated alloantigen exposure, we demonstrate that αCD154 is not sufficient and regulatory T cells (Tregs) are necessary to induce and sustain αCD154-mediated alloreactive Tconv anergy. Transient depletion of Tregs disrupted the induction of αCD154-mediated Tconv anergy, and in mice with established tolerance, Treg depletion transcriptionally and functionally reinvigorated previously anergic Tconvs. Mechanistically, Treg depletion increased IL-2 availability and IL-2R signaling in Tconvs, and exogenous IL-2 could bypass Treg-mediated control to partially restore Tconv function. Thus, the state of αCD154-mediated Tconv anergy is less cell-intrinsic than previously thought and requires Tregs to limit IL-2 availability for both its induction and its continuous enforcement. Selecting immunosuppressive drugs that preserve this Treg function may be critical for achieving stable clinical transplantation tolerance.

Graphical Abstract
graphical abstract
Supplemental material

View

View Figure 3G publication license

View Sup Fig 7B publication license

View Fig 1E publication license

View Sup Fig 8D publication license

View Sup Fig 1A publication license

View Fig 6B publication license

View Fig 6G publication license

View Fig 1A publication license

View Fig 1G publication license

View Fig 2A publication license

View Fig 3A publication license

View Fig 6D publication license

View Fig 3E publication license

View Fig 5A publication license

View Sup Fig 5A publication license

View Fig 4A publication license

View Sup Fig 4D publication license

View Sup Fig 2E publication license

View Sup Fig 8A publication license

View Sup Fig 7D publication license

View Graphical abstract publication license

Version history
  • Version 1 (November 19, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts